DermaKnowlogy ApS: Financial statements 2020
CVR: 10055318
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
DermaKnowlogy ApS (CVR 10055318) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -559,162 and a net result of DKK -640,585 compared with DKK -1,492,358 the year before. Equity in the 2020 report amounted to DKK -2,849,470.
- Gross Profit
- DKK -559,162
- Profit/Loss
- DKK -640,585
- Equity
- DKK -2,849,470
- Total Assets
- DKK 834,098
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -559 t. | -641 t. | -2.8 mio. | - |
| 2019 | - | -1.7 mio. | -1.5 mio. | -2.2 mio. | - |
| 2018 | - | -538 t. | -475 t. | -717 t. | - |
| 2017 | - | -287 t. | -231 t. | -241 t. | - |
| 2016 | - | -6 t. | -6 t. | -11 t. | - |
Official annual report
How creditworthy is DermaKnowlogy ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
DermaKnowlogy ApS has published its annual report for 2019. Gross profit came to DKK -1,684,912, and the net result was DKK -1,492,358.
About DermaKnowlogy ApS
DermaKnowlogy ApS is a Danish company of the type Anpartsselskab based in Fårup, founded in 2000. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named SCAN CARE ApS and PBH 27.488 ApS. The management consists of Peter Bogh. The board consists of Mikkel Egelund Jensen (chair), Peter Bogh and Uffe Koppelhus. The company is owned by DERMA PHARM A/S and Uffe Koppelhus Holding ApS. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -618,011 and a net result of DKK -607,032 compared with DKK -882,036 the year before. Equity in the 2025 report amounted to DKK -6,915,548.